Literature DB >> 21952098

Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core set.

Domien Gijbels1, Ulrik Dalgas, Anders Romberg, Vincent de Groot, Francois Bethoux, Claude Vaney, Benoit Gebara, Carme Santoyo Medina, Heigo Maamâgi, Kamila Rasova, Benoit Maertens de Noordhout, Kathy Knuts, Peter Feys.   

Abstract

BACKGROUND: Many different walking capacity test formats are being used. It is unclear whether walking speed, obtained from short tests, and walking distance, obtained from long tests, provide different clinical information.
OBJECTIVES: To determine the differential effect of various short and long walk test formats on gait velocity, and the actual relationship between walking speed and walking distance in multiple sclerosis (MS) patients with diverse ambulation status.
METHODS: A cross-sectional multicentre study design was applied. Ambulatory MS patients (Expanded Disability Status Scale (EDSS) 0-6.5; n = 189) were tested at 11 sites. Short tests consisted of the Timed 25-Foot Walk (static start, fastest speed) and 10-Metre Walk Test (dynamic start, usual and fastest speed). Long tests consisted of the 2- and 6-Minute Walk Tests (fastest speed). Subjects were divided into mild (EDSS 0-4; n = 99) or moderate (EDSS 4.5-6.5; n = 79) disability subgroups.
RESULTS: In both subgroups, the start protocol, instructed pace and length of test led to significantly different gait velocities. Fastest walking speed and 6-Minute walking distance showed the strongest correlation (R (2) = 0.78 in mild and R (2) = 0.81 in moderate MS; p < 0.01). Short tests' relative estimation errors for 6-Minute walking distance were 8-12% in mildly and 15-16% in moderately affected subjects. Based on the 2-Minute Walk Test, estimation errors significantly reduced to approximately 5% in both subgroups.
CONCLUSIONS: A single short test format at fastest speed accurately describes an MS patient's general walking capacity. For intervention studies, a long test is to be considered. We propose the Timed 25-Foot Walk and 2-Minute Walk Test as standards. Further research on responsiveness is needed.

Entities:  

Mesh:

Year:  2011        PMID: 21952098     DOI: 10.1177/1352458511420598

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  32 in total

Review 1.  Next Steps in Wearable Technology and Community Ambulation in Multiple Sclerosis.

Authors:  Mikaela L Frechette; Brett M Meyer; Lindsey J Tulipani; Reed D Gurchiek; Ryan S McGinnis; Jacob J Sosnoff
Journal:  Curr Neurol Neurosci Rep       Date:  2019-09-04       Impact factor: 5.081

2.  A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis.

Authors:  Andrew D Goodman; Theodore R Brown; Randall T Schapiro; Michael Klingler; Ron Cohen; Andrew R Blight
Journal:  Int J MS Care       Date:  2014

3.  Telemedicine for Monitoring MS Activity and Progression.

Authors:  Nuria Sola-Valls; Yolanda Blanco; Maria Sepúlveda; Eugenia Martinez-Hernandez; Albert Saiz
Journal:  Curr Treat Options Neurol       Date:  2015-11       Impact factor: 3.598

4.  Dynamometer-based measure of spasticity confirms limited association between plantarflexor spasticity and walking function in persons with multiple sclerosis.

Authors:  Theodore R Kremer; Linda R Van Dillen; Joanne M Wagner
Journal:  J Rehabil Res Dev       Date:  2014

5.  Feasibility of an International Multiple Sclerosis Rehabilitation Data Repository: Perceived Challenges and Motivators for Sharing Data.

Authors:  Elissa Held Bradford; Ilse Baert; Marcia Finlayson; Peter Feys; Joanne Wagner
Journal:  Int J MS Care       Date:  2018 Jan-Feb

6.  Validation of the 2-Minute Walk Test with the 6-Minute Walk Test and Other Functional Measures in Persons with Multiple Sclerosis.

Authors:  David A Scalzitti; Kenneth J Harwood; Joyce R Maring; Susan J Leach; Elizabeth A Ruckert; Ellen Costello
Journal:  Int J MS Care       Date:  2018 Jul-Aug

7.  An exploration of impaired walking dynamics and fatigue in multiple sclerosis.

Authors:  Janina M Burschka; Philipp M Keune; Uwe Menge; Ulrich Hofstadt-van Oy; Patrick Oschmann; Olaf Hoos
Journal:  BMC Neurol       Date:  2012-12-27       Impact factor: 2.474

8.  Motor fatigue measurement by distance-induced slow down of walking speed in multiple sclerosis.

Authors:  Rémy Phan-Ba; Philippe Calay; Patrick Grodent; Gael Delrue; Emilie Lommers; Valérie Delvaux; Gustave Moonen; Shibeshih Belachew
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

9.  Gait variability and multiple sclerosis.

Authors:  Michael J Socie; Jacob J Sosnoff
Journal:  Mult Scler Int       Date:  2013-03-03

10.  Sustained-release fampridine (4-aminopyridine) in multiple sclerosis: efficacy and impact on motor function.

Authors:  Meheroz H Rabadi; Kimberly Kreymborg; Andrea S Vincent
Journal:  Drugs R D       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.